The shares of Glenmark Pharmaceuticals surged 20% on Friday, July 11, to a days high of Rs 2,286 following a landmark $2 billion licensing deal with U.S. pharma giant AbbVie for its cancer drug, ISB 2001.
Dixon Technologies India Ltd., founder and chairman Sunil Vachani has sold 16.7 lakh shares, marking a 2.77% stake at Rs 13,301.47 apiece. He has offloaded shares worth Rs 2,221 crore in the bulk deal.
Oswal Pumps Ltd. raised Rs 416.20 crore from anchor investors on Thursday ahead of the launch of its initial public offering. The company allotted 67.78 lakh shares at Rs 614 apiece to 25 anchor investors, according to an exchange filing.
Mirae Asset Mutual Fund obtained a 0.31% stake worth Rs 199.9 crore in Aditya Birla Capital Ltd. through open market transactions on Wednesday. Mirae Asset acquired 82.42 lakh shares at 242.65 apiece, as per BSE block deal data. Motilal Oswal Mutual Fund bought 82.42 lakh shares or a 0.31% stake and Goldman Sachs Funds - Goldman Sachs India Equity Portfolio mopped up 33.63 lakh shares or a 0.12% stake.
Major financial institutions like Goldman Sachs and Morgan Stanley acquired a 1.45% stake in Suzlon Energy for Rs 1,309 crore, prompting a slight increase in the company's share price. Simultaneously, Suzlon's promoter entities reduced their holdings to 11.8%. In a separate transaction, Shankara Building Products' promoter divested a 7.
Around 29 equity mutual funds have delivered over 25% CAGR in both the last three and five years, as per ETMutualFunds analysis of 199 funds with five-year track records. Notable performers include Bandhan Core Equity Fund, Bandhan Small Cap Fund, and Edelweiss Mid Cap Fund, which posted 28.57% and 34.13% CAGR over three and five years, respectively.
Twenty-seven equity mutual fund schemes have delivered over 25% CAGR in both three- and five-year periods, with HDFC Mutual Fund leading the pack. Funds like Quant Small Cap, Franklin India Prima, and Motilal Oswal Midcap stood out for their stellar performance. The analysis spans all equity categories and is based on regular, growth options—not a recommendation.
Mutual funds' cash holdings rose by Rs 17,361 crore in April amid market volatility and slowing inflows. With valuations still elevated, fund houses prefer holding cash, focusing on large-caps, hybrid strategies, and selective deployment into small-cap opportunities.
Around 88% of equity mutual funds delivered negative returns in 2025 so far, with 44 schemes posting double-digit losses. Small-cap and ELSS funds were hit the hardest. Only 33 funds managed gains, led by ICICI Prudential and HDFC schemes. Investors are advised to base decisions on goals and risk appetite.
Mutual funds' cash holdings have surged to a 15-year high in March 2025, signaling fund managers' cautious approach amid limited attractive investment opportunities. This elevated cash level mirrors trends seen in 2011 and 2018, preceding Nifty rallies concentrated in large-cap stocks. Investors should temper return expectations and prioritize portfolio quality, asset allocation, and risk management.